Observational studyBMJ open2026
Lead and mercury exposure in pregnant women in the UK: a cross-sectional observational study (the PEAR Study).
Observational study in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesLead and mercury are recognised as critical determinants of population health, especially for children and pregnant women. Few UK cohorts have measured lead or mercury in pregnant women since 1990. The aims of this study are to: (1) quantify lead and mercury exposures in a sample of pregnant women in the UK; (2) document concentrations over time in pregnant women in the UK; and (3) compare concentrations with international data.
designWhole blood samples were obtained from pregnant women in a quantitative arm of the Pregnancy, the Environment And nutRition Study in a cross-sectional observational study design. The samples were analysed by inductively coupled plasma mass spectrometry (Health and Safety Executive, Buxton, UK).
settingCommunity-based with recruitment through a hospital antenatal clinic in south-west England.
participantsWomen ≥18 years old and ≥11 weeks pregnant by last menstrual period. PRIMARY OUTCOME MEASURES: Whole blood lead and speciated mercury concentrations.
resultsThe whole blood lead concentration was: mean 5.8 (SD 6.2), median 4.6 (IQR 3.5, 5.9), range 1.7-78.1 µg/L (n=262; gestational age range by scan 8.3-15.9 weeks). These values are about 84% lower than in pregnant women in the UK Avon Longitudinal Study of Parents and Children (ALSPAC; 1991-1992), about 47% lower than in the UK Born in Bradford (BiB) study (2007-2011) and about 34% lower than in White women in the UK Mother's and Baby's Exposure to Lead study (MaBEL; 2011). Blood total mercury concentration was: mean 0.83 (SD 0.64), median 0.69 (IQR 0.34, 1.19), range 0.07-3.40 (about 60% lower than in pregnant women in ALSPAC and about 37% lower than in BiB). These results are similar to contemporary concentrations found in Europe and the USA.
conclusionsBlood concentrations of lead and mercury in pregnant women in the UK have declined considerably since the early 1990s. However, no safe levels have previously been identified for adverse effects on cognition, preterm birth rate or coronary heart disease prevalence. These data will contribute to the ongoing development of public health advice. STUDY REGISTRATION: ISTCTN92638336.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.